| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director
2 companies
Steinhart Richard I serves as a Chief Financial Officer at BTAI and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 4 buys and 9 sells. Those positions are worth an estimated $32K at current prices.
Historically, Steinhart Richard I's trades have earned a strong insider score of 87/100 across 7 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +82.7%.
The biggest single holding is BTAI (~$25K) as Chief Financial Officer. The recent filings there lean toward selling, a net 18,883 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2024 | BTAI Bioxcel Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 577 | $0.36 | $206.98 | -1.4% | -64.9% | -71.1% | |
| Oct 3, 2024 | BTAI Bioxcel Therapeutics, Inc. | Chief Financial Officer | Sell | 7,175 | $0.55 | $3,946.25 | -26.1% | -28.7% | -71.3% | |
| Sep 16, 2024 | BTAI Bioxcel Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 356 | $0.69 | $245.60 | -5.4% | -36.5% | -70.8% | |
| Jun 17, 2024 | BTAI Bioxcel Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 372 | $1.26 | $469.54 | -6.4% | -51.9% | -92.3% | |
| Apr 4, 2024 | BTAI Bioxcel Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 1,069 | $2.64 | $2,816.81 | -18.3% | -59.9% | -96.2% | |
| May 15, 2023 | BTAI Bioxcel Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 5,000 | $27.17 | $135,863.50 | -76.9% | -84.1% | -92.2% | |
| Mar 15, 2023 | BTAI Bioxcel Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 2,084 | $19.50 | $40,638.00 | -58.1% | +2.8% | -85.4% | |
| Feb 1, 2021 | BTAI Bioxcel Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 3,750 | $48.15 | $180,562.50 | -71.4% | - | - | |
| Dec 3, 2018 | BTAI Bioxcel Therapeutics, Inc. | Chief Financial Officer | Buy | 500 | $5.20 | $2,599.95 | +50.0% | - | - | |
| Nov 30, 2018 | BTAI Bioxcel Therapeutics, Inc. | Chief Financial Officer | Buy | 500 | $5.00 | $2,500.00 | +100.0% | - | - |